Clinical Oncology Next Generation Sequencing (NGS) Market Massive Growth Digging New Opportunities By 2030 with Illumina, Inc., Myriad Genetics, Inc., QIAGEN

The Global Clinical Oncology Next Generation Sequencing Market Size was valued at USD 339.10 million in 2022 and is predicted to reach USD 1.18 billion by 2030, increasing at a CAGR of +14% from 2023 to 2030.

Next-generation sequencing is a technique that helps in conducting various reactions simultaneously, through which DNA or RNA can be sequenced. During recent years, NGS has revolutionized cancer genetics by providing access to genomic and transcriptomic data to the researchers in this field. Most of the oncologists in developed nations such as the United States use the technique of NGS to provide better treatment for their patients.

A new analytical research report on Global Clinical Oncology Next Generation Sequencing (NGS) Market, titled as Clinical Oncology Next Generation Sequencing (NGS) has been newly published by Report Consultant to its widespread database. It gives a detailed elaboration on global Clinical Oncology Next Generation Sequencing (NGS) market including different segments and sub-segments such as type, size, applications, end-users, key players, and major key geographies.

Try a sample of this Market report now! @
https://globalmarketvision.com/sample_request/159594

Top Companies of Clinical Oncology Next Generation Sequencing (NGS) Market:
• Agilent Technologies, Inc.
• Caris Life Sciences
• F. Hoffmann-La Roche Ltd
• FOUNDATION MEDICINE, INC.
• Illumina, Inc.
• Myriad Genetics, Inc.
• Oxford Nanopore Technologies
• Paradigm Diagnostics, Inc.
• QIAGEN
• Thermo Fisher Scientific Inc.

Clinical oncology next-generation sequencing Market by Segmentation:
By Component:
• Sequencing Platforms
• Sequencing Products
• Kits and Reagents
• Services

By Technology:
• Ion Semiconductor Sequencing
• Pyro-Sequencing
• Synthesis Sequencing (SBS)
• Real Time Sequencing (SMRT)
• Ligation Sequencing
• Reversible Dye Termination Sequencing
• Nano-Pore Sequencing

By Application:
• Whole Tumor Genome Sequencing
• Whole Tumor Exome Sequencing
• Targeted Tumor Genome Profiling
• Tumor Transcriptome Sequencing
• Tumor-normal Comparisons
• Others

By End User:
• Hospital Laboratories
• Clinical Research Organizations
• Diagnostic Laboratories
• Others

This Clinical Oncology Next Generation Sequencing (NGS) market report also gives a description of the complete market analysis with inputs from industry experts. A market research analysis and estimations carried out in this Clinical Oncology Next Generation Sequencing (NGS) report aids businesses in gaining knowledge about what is already there in the market, what the market looks forward to, the competitive background and steps to be followed for outdoing the rivals.

The clinical oncology next-generation sequencing (NGS) market is segmented on the basis of technology, workflow, application, and end user. Based on technology the market is segmented as, whole exome sequencing, whole genome sequencing and targeted sequencing & resequencing. On the basis of workflow, the market is segmented as, NGS data analysis, NGS pre-sequencing and NGS sequencing. The clinical oncology next-generation sequencing (NGS) market is categorized based on application such as companion diagnostics, screening and other applications. Similarly, on the basis of end user, the market is segmented as, hospitals & clinics and laboratories.

Request for Buy Report @
https://globalmarketvision.com/checkout/?currency=USD&type=single_user_license&report_id=159594

In This Study, The Years Considered To Estimate The Size Of Clinical Oncology Next Generation Sequencing (NGS) Market Are As Follows:
History Year: 2015-2022
Base Year: 2022
Estimated Year: 2023
Forecast Year 2023 to 2030

Request a customized copy of Clinical Oncology Next Generation Sequencing (NGS) Market report
We are grateful to you for reading our report. If you wish to find more details of the report or want customization, contact us. You can get a detailed of the entire research here. If you have any special requirements, please let us know and we will offer you the report you want.

Get in Touch with Us
Sarah Ivans | Business Development
Phone: +1 617 297 8902
Email: sales@globalmarketvision.com
Global Market Vision
Website: www.globalmarketvision.com

About Global Market Vision
Global Market Vision consists of an ambitious team of young, experienced people who focus on the details and provide the information as per customer's needs. Information is vital in the business world, and we specialize in disseminating it. Our experts not only have in-depth expertise, but can also create a comprehensive report to help you develop your own business.
With our reports, you can make important tactical business decisions with the certainty that they are based on accurate and well-founded information. Our experts can dispel any concerns or doubts about our accuracy and help you differentiate between reliable and less reliable reports, reducing the risk of making decisions. We can make your decision-making process more precise and increase the probability of success of your goals.

This release was published on openPR.